Definitive Contract 75N92020C00035
Award Date
9/29/20
Potential Completion Date
9/28/22
Potential Value
$18M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Quanterix Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Quanterix Corporation, a manufacturer of advanced biomarker detection technology. The $84,525 contract supports Quanterix's work on the Rapid Acceleration of Diagnostics (RADx) initiative for COVID-19 testing. Quanterix is providing specialized Simoa instruments, assay kits, and research services to federal agencies like the NIH,...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $15 million firm fixed price purchase order to National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, for the Rapid Acceleration of Diagnostics (RADX) Initiative - Phase 0. As part of the RADX Initiative to accelerate the development, testing, and implementation of novel diagnostics for COVID-19, this contract will support Venturewell's efforts to advance diagnostics through...
The National Institutes of Health (NIH) awarded a $92,645,361.50 firm-fixed-price contract to Quidel Corporation to provide rapid COVID-19 antigen test kits under the Rapid Acceleration of Diagnostics (RADx) initiative. The contract, which does not have a set-aside designation, runs through April 30, 2025 and requires Quidel to deliver the tests from its facilities in San Diego, California. Quidel is a manufacturer of medical diagnostics and supplies, and has received numerous federal...
This federal contract award, valued at $14,525.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Quanterix Corporation, a life sciences company that specializes in ultra-sensitive digital biomarker detection technology. The contract, titled "NICHD - INFLIGHT V2 ADVANTAGE KIT", is a firm-fixed-price purchase order with a completion date of September 30, 2024. Quanterix has also been awarded an indefinite delivery contract (IDV) by the Department...
This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Detect Inc. for the Rapid Acceleration of Diagnostics (RADx) Tech II program. The contract is valued at $8,085,388.00 and has a firm fixed price pricing type. The contract is for the "Expanded Manufacturing and Commercialization of 'Detect' COVID-19 Test: Highly Scalable, Affordable, At-Home Rapid Test" project, with a completion date of October 13, 2022. This contract...
The Department of Health and Human Services (HHS) National Institutes of Health National Heart Lung and Blood Institute awarded a $5,253,450.00 firm fixed-price contract to Maxim Biomedical, Inc. to provide RADX TECH SARS-COV-2 antigen rapid tests. The contract has an estimated completion date of August 27, 2023 and was awarded on August 28, 2020. Maxim Biomedical is a small disadvantaged, woman-owned, Asian-Pacific American owned business that specializes in medical device manufacturing,...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization based in Hadley, Massachusetts. The $2,097,064.03 firm fixed-price delivery order is for clinical evaluation services in support of the Rapid Acceleration of Diagnostics (RADx) initiative, which aims to...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $14.9 million purchase order contract to the National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, to provide infrastructure support for the Rapid Acceleration of Diagnostics Initiative. The one-year, time and materials contract will support the NIH's RADX program, which aims to accelerate the development, commercialization, and implementation of novel diagnostics...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Definitive Firm Fixed Price contract to Qorvo Biotechnologies LLC, a subsidiary of Qorvo, Inc., to secure an Emergency Use Authorization (EUA) approved point-of-care (POC) antigen test system and increase the incremental daily cartridge production capacity to 54,800 tests. The contract, valued at $23,882,600.00, is part of the Rapid Acceleration of Diagnostic Testing (RADX)...
This is a definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The $33,379,628.30 firm fixed-price contract is for NHLBI's Rapid Acceleration of Diagnostics (RADx) initiative, providing ITAP consultants and infrastructure support. The contract has a period of...